LivaNova to Present Data at 2024 American Epilepsy Society Meeting
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, held December 6-10 in Los Angeles. The company will showcase its therapies and technologies for drug-resistant epilepsy through several…
GeneDx Expands Exome Testing Access for Pediatric Epilepsy with New Partners
GeneDx (Nasdaq: WGS), a leader in improving health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines (Nasdaq: PRAX), and Stoke Therapeutics (Nasdaq: STOK) as the founding partners of its Patient Access Program for pediatric epilepsy, offering…
Veterans’ Research Foundation Highlights CyPath® Lung’s Addition to Federal Supply Schedule
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive tests for early-stage cancer detection, will join Federal Supply System (FSS) officials today in a joint presentation. The event will highlight the Veterans Health Administration (VHA) award that…
ICON Survey Highlights Continued AI and Digital R&D Investment Amid Siloed Adoption
ICON plc (NASDAQ: ICLR), a global leader in clinical research powered by healthcare intelligence, today revealed the results of a recent global survey involving 101 biotech and pharma professionals from Europe and North America. The survey aimed to assess the…
Foundation Medicine Grants Support Organizations Addressing Biomarker Testing Disparities in Breast and Prostate Cancer
Foundation Medicine, Inc. has announced the awarding of two grants to organizations focused on reducing disparities in biomarker testing for breast and prostate cancer. These grants follow an open call for proposals in April 2024, where Foundation Medicine sought collaborations…
Hippocratic AI Partners with Nurses on Boards Coalition to Empower Nurses in Healthcare Tech
Hippocratic AI, the company developing the first safety-focused Large Language Model (LLM) for healthcare, has announced a strategic partnership with the Nurses on Boards Coalition (NOBC) to empower nurses in healthcare technology. This partnership reflects Hippocratic AI’s commitment to fostering…
Novocure Announces PANOVA-3 Phase 3 Trial Results for TTFields in Pancreatic Cancer
Novocure (NASDAQ: NVCR) announced that its pivotal Phase 3 PANOVA-3 trial successfully met its primary endpoint, showing a statistically significant improvement in median overall survival (mOS) compared to the control arm. The trial assessed the combination of Tumor Treating Fields…
Agiliti Unveils New Adapt Line™ of Therapeutic Support Surfaces for Enhanced Comfort and Outcomes
Agiliti, a leading provider of medical device solutions, has announced the launch of its new Adapt Line™ of therapeutic hospital support surfaces. These surfaces are clinically designed to improve patient comfort and reduce the risk of pressure injuries caused by…
Flatiron Health to Present Research at San Antonio Breast Cancer Symposium 2024
Flatiron Health today announced its participation in the upcoming San Antonio Breast Cancer Symposium (SABCS), with four accepted abstracts for poster presentation. Additionally, the company will sponsor a session titled “How Holistic Real-World Evidence Generation Advances Breast Cancer Research.” “We…
Almirall Launches The Hive, a New Innovation Hub for Life Sciences
Almirall, a global pharmaceutical company focused on medical dermatology, today unveiled “The Hive,” a groundbreaking scientific research hub located at its R&D center in Barcelona, Spain. The Hive is designed to promote collaboration among researchers from biotech companies, start-ups, academia,…
Carlsmed Receives FDA Clearance for aprevo® Cervical Fusion Device
Carlsmed, Inc., a MedTech company specializing in AI-driven personalized spine surgery, today announced that it has received FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This achievement highlights Carlsmed’s dedication to advancing patient-specific spine surgery solutions aimed at…
Covenant Behavioral Health Gets Grant to Enhance ADHD Care for Military Families
Covenant Behavioral Health, a leading healthcare provider for active-duty personnel, veterans, and their families, has received the inaugural grant from Qbtech’s new QbAccess program. This initiative is designed to offer non-profit healthcare organizations access to Qbtech’s FDA-cleared objective ADHD testing…